Contact
Header_1077x260px_About_Profil.jpg

"Profil World" - The clinical diabetes research newsletter - July 2018

Dr.
Posted by Dr. Lars Bochmann on Jul 18, 2018 5:21:00 PM

Dear all,

Greetings from Germany! I am happy to share with you the newest edition of "Profil World" - our newsletter filled with information about clinical research in diabetes and obesity.

FibroScan® screening of potential trial participants at Profil

profilProfil uses the FibroScan® medical device (Echosens, Paris) for a non-invasive and cost-effective staging of liver fibrosis and liver fat. Transient elastography with controlled attenuation parameter is used to screen potential trial participants for the presence of liver fat and stiffness. Read more about this technology.

 

Beyond HbA1c: CGM based outcome measures in clinical trials

CGM-based-outcome-banner-1In our last online seminar the renowned scientist Prof. Hans de Vries gave insights on CGM based outcome measures in clinical trials. In this online seminar learn about the draft guideline on clinical investigation of medicinal products in the treatment and prevention of diabetes mellitus, defining the right outcome measures using CGM for your trial and Profil's capabilities in the field of CGM based outcome measures. Watch the on-demand online seminar.

 

D4kids: Profil joined a new pan-European Artificial Pancreas initiative

containing-851228_1280_Profil is part of the new Diabeloop for children (D4kids) pan-European consortium for functionally enhancing an Artificial Pancreas (AP) system to better serve the needs and requirements of children with type 1 diabetes and their families. Read about the project and its ambition in our blog post.

 

 

Profil recently published a study on ultra-rapid BioChaperone Lispro

0090_RGB__Read our publication on the safety and efficacy of BioChaperone Lispo, an ultra-rapid formulation of insulin lispro in people with type 1 diabetes. BioChaperone Lispro improves postprandial blood glucose vs insulin lispro when administered at mealtime.

 

 

Meet us at upcoming conferences 

Fotolia_14.06.2013_23704610__

Are you interested in knowing more about Profil? We attend all major conferences focused on diabetes, so if you are planning to go to any upcoming conference, we would love to schedule a meeting and tell you more about our expertise!

Upcoming events: BioPharm America in Boston (9/5-6/2018), EASD in Berlin (10/1-5/2018)

 

We wish you a good week and look forward to the next "Profil World",

Dr Lars Bochmann - Director Scientific Communication, Profil

 

Topics: About Profil